Search :
Sign in or Register  
Welcome Sign in or Don't have an account?Register

FLT4

This gene encodes a tyrosine kinase receptor for vascular endothelial growth factors C and D. The protein is thought to be involved in lymphangiogenesis and maintenance of the lymphatic endothelium. Mutations in this gene cause hereditary lymphedema type IA. [provided by RefSeq, Jul 2008]
Full Name
Fms Related Tyrosine Kinase 4
Function
Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFC and VEGFD, and plays an essential role in adult lymphangiogenesis and in the development of the vascular network and the cardiovascular system during embryonic development. Promotes proliferation, survival and migration of endothelial cells, and regulates angiogenic sprouting. Signaling by activated FLT4 leads to enhanced production of VEGFC, and to a lesser degree VEGFA, thereby creating a positive feedback loop that enhances FLT4 signaling. Modulates KDR signaling by forming heterodimers. The secreted isoform 3 may function as a decoy receptor for VEGFC and/or VEGFD and play an important role as a negative regulator of VEGFC-mediated lymphangiogenesis and angiogenesis. Binding of vascular growth factors to isoform 1 or isoform 2 leads to the activation of several signaling cascades; isoform 2 seems to be less efficient in signal transduction, because it has a truncated C-terminus and therefore lacks several phosphorylation sites. Mediates activation of the MAPK1/ERK2, MAPK3/ERK1 signaling pathway, of MAPK8 and the JUN signaling pathway, and of the AKT1 signaling pathway. Phosphorylates SHC1. Mediates phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase. Promotes phosphorylation of MAPK8 at 'Thr-183' and 'Tyr-185', and of AKT1 at 'Ser-473'.
Biological Process
Blood vessel morphogenesis Source: UniProtKB
Cellular response to vascular endothelial growth factor stimulus Source: UniProtKB
Hematopoietic progenitor cell differentiation Source: GO_Central
Lung alveolus development Source: Ensembl
Lymphangiogenesis Source: UniProtKB
Lymph vessel development Source: BHF-UCL
Negative regulation of apoptotic process Source: UniProtKB
Peptidyl-tyrosine phosphorylation Source: UniProtKB
Positive regulation of cell population proliferation Source: UniProtKB
Positive regulation of endothelial cell migration Source: UniProtKB
Positive regulation of endothelial cell proliferation Source: UniProtKB
Positive regulation of ERK1 and ERK2 cascade Source: UniProtKB
Positive regulation of JNK cascade Source: UniProtKB
Positive regulation of kinase activity Source: GO_Central
Positive regulation of MAPK cascade Source: UniProtKB
Positive regulation of protein kinase C signaling Source: UniProtKB
Positive regulation of protein phosphorylation Source: UniProtKB
Positive regulation of vascular endothelial growth factor production Source: UniProtKB
Protein autophosphorylation Source: UniProtKB
Regulation of blood vessel remodeling Source: UniProtKB
Respiratory system process Source: Ensembl
Sprouting angiogenesis Source: UniProtKB
Transmembrane receptor protein tyrosine kinase signaling pathway Source: GO_Central
Vascular endothelial growth factor receptor signaling pathway Source: MGI
Vascular endothelial growth factor signaling pathway Source: UniProtKB
Vasculature development Source: UniProtKB
Cellular Location
Cytoplasm; Cell membrane; Nucleus. Ligand-mediated autophosphorylation leads to rapid internalization.
Isoform 1&2: Cell membrane. Ligand-mediated autophosphorylation leads to rapid internalization.
Isoform 3: Cytoplasm; Secreted
Involvement in disease
Lymphatic malformation 1 (LMPHM1):
A form of primary lymphedema, a disease characterized by swelling of body parts due to developmental anomalies and functional defects of the lymphatic system. Patients with lymphedema may suffer from recurrent local infections. LMPHM1 is an autosomal dominant form with variable expression and severity. Onset is usually at birth or in early childhood but can occur later. Affected individuals manifest lymphedema, predominantly in the lower limbs, and hypoplasia of lymphatic vessels. Additional features are hemangioma and nail dysplasia or papillomatosis.
Hemangioma, capillary infantile (HCI):
A condition characterized by dull red, firm, dome-shaped hemangiomas, sharply demarcated from surrounding skin, usually presenting at birth or occurring within the first two or three months of life. They result from highly proliferative, localized growth of capillary endothelium and generally undergo regression and involution without scarring.
Congenital heart defects, multiple types, 7 (CHTD7):
An autosomal dominant disorder with incomplete penetrance characterized by congenital developmental abnormalities involving structures of the heart. Common defects include tetralogy of Fallot, pulmonary stenosis or atresia, absent pulmonary valve, right aortic arch, double aortic arch, and major aortopulmonary collateral arteries.
Topology
Extracellular: 25-775
Helical: 776-796
Cytoplasmic: 797-1363
PTM
Autophosphorylated on tyrosine residues upon ligand binding. Autophosphorylation occurs in trans, i.e. one subunit of the dimeric receptor phosphorylates tyrosine residues on the other subunit. Phosphorylation in response to H2O2 is mediated by a process that requires SRC and PRKCD activity. Phosphorylation at Tyr-1068 is required for autophosphorylation at additional tyrosine residues. Phosphorylation at Tyr-1063 and Tyr-1337 is important for interaction with CRK and subsequent activation of MAPK8. Phosphorylation at Tyr-1230, Tyr-1231 and Tyr-1337 is important for interaction with GRB2 and subsequent activation of the AKT1 and MAPK1/ERK2 and/or MAPK3/ERK1 signaling pathways. In response to endothelial cell adhesion onto collagen, can also be phosphorylated in the absence of FLT4 kinase activity by SRC at Tyr-830, Tyr-833, Tyr-853, Tyr-1063, Tyr-1333, and Tyr-1337.

Anti-FLT4 antibodies

+ Filters
Loading...
Submit A Review Fig.3 Signaling pathways in cancers. (Creative Biolabs Authorized) Fig.4 Protocols troubleshootings & guides. (Creative Biolabs Authorized) Submit A Review Fig.3 Signaling pathways in cancers. (Creative Biolabs Authorized) Fig.4 Protocols troubleshootings & guides. (Creative Biolabs Authorized)
Target: FLT4
Host: Human
Antibody Isotype: IgG1
Specificity: Human
Clone: CBXC-0842
Application*: F
Target: FLT4
Host: Rabbit
Antibody Isotype: IgG
Specificity: Mouse
Clone: CBFYC-2707
Application*: E
Target: FLT4
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBXF-1596
Application*: E, WB
Target: FLT4
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: CBXF-3096
Application*: E, WB
Target: FLT4
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: CBXF-3095
Application*: E, WB
Target: FLT4
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: CBXF-3092
Application*: E, WB
Target: FLT4
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: CBXF-3091
Application*: E, WB
Target: FLT4
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: CBXF-3090
Application*: E
Target: FLT4
Host: Mouse
Antibody Isotype: IgG
Specificity: Human, Mouse, Rat
Clone: CBXF-1756
Application*: WB, IP, IF, E
Target: FLT4
Host: Mouse
Antibody Isotype: IgG2a, κ
Specificity: Human
Clone: CBXF-0765
Application*: SE, E, WB
Target: FLT4
Host: Rat
Antibody Isotype: IgG2a, κ
Specificity: Human, Mouse
Clone: CBXF-0764
Application*: F, C, P, IP, WB
Target: FLT4
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBXF-3776
Application*: WB
Target: FLT4
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBXF-0762
Application*: E, IH, WB
Target: FLT4
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBXF-3558
Application*: WB
Target: FLT4
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBXF-2339
Application*: E, F, C, P, IP, WB
Target: FLT4
Host: Rat
Antibody Isotype: IgG2a, κ
Specificity: Mouse
Clone: CBXF-0761
Application*: WB, P, C, IP
Target: FLT4
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human
Clone: 818CT12.1.1
Application*: WB, P
Target: FLT4
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: 4H4
Application*: E, WB, P, IF, F
Target: FLT4
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: CBXF-0760
Application*: WB, IH, F
Target: FLT4
Host: Mouse
Antibody Isotype: IgG1, κ
Specificity: Human
Clone: 44CT92.4.4
Application*: IH, WB
Target: FLT4
Host: Rat
Antibody Isotype: IgG2a, κ
Specificity: Mouse
Clone: AFL4
Application*: F, IH, FN, IP, WB
Target: FLT4
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: CBYY-1545
Application*: IH
Target: FLT4
Host: Rat
Antibody Isotype: IgG2
Specificity: Mouse
Clone: CBYY-1065
Application*: WB, IH, P
Target: FLT4
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBYY-1064
Application*: WB, P, F
Target: FLT4
Host: Mouse
Antibody Isotype: IgG1
Specificity: Mouse
Clone: CBYY-1063
Application*: B
Target: FLT4
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBYY-1062
Application*: WB, F, E, IH, MC
Target: FLT4
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBYY-1059
Application*: E, F, IH, IP, WB
Target: FLT4
Host: Rat
Antibody Isotype: IgG1
Specificity: Human, Mouse
Clone: CBYY-1058
Application*: WB, E, IP
Target: FLT4
Host: Rat
Antibody Isotype: IgG2
Specificity: Mouse
Clone: CBYY-1057
Application*: IH, WB
Target: FLT4
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human
Clone: CBYY-1056
Application*: WB
Target: FLT4
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBYY-1055
Application*: WB, E
Target: FLT4
Host: Mouse
Antibody Isotype: IgG1, κ
Specificity: Human
Clone: CBYY-1054
Application*: IH, WB
Target: FLT4
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBYY-1053
Application*: WB
Target: FLT4
Host: Rabbit
Antibody Isotype: IgG
Specificity: Human
Clone: CBYY-1052
Application*: WB
Target: FLT4
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBYY-1051
Application*: WB, E, IP
Target: FLT4
Host: Rat
Antibody Isotype: IgG1
Specificity: Mouse
Clone: CBYY-1050
Application*: WB
Target: FLT4
Host: Rat
Antibody Isotype: IgG2a
Specificity: Mouse
Clone: CBYY-1049
Application*: EC
Target: FLT4
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBYY-1048
Application*: EC
Target: FLT4
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBYY-1047
Application*: WB, IH, IC
Target: FLT4
Host: Rat
Antibody Isotype: IgG2a, κ
Specificity: Mouse
Clone: CBYY-1046
Application*: F
Target: FLT4
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBYY-1045
Application*: F, E
Target: FLT4
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: CAP774
Application*: FC, IHC, WB
Target: FLT4
Host: Mouse
Antibody Isotype: IgG
Specificity: Human, Mouse
Clone: CBAb106
Application*: WB, IH, FC
Target: FLT4
Host: Rabbit
Antibody Isotype: IgG
Specificity: Human
Clone: D1J9Z
Application*: WB, IP
Target: FLT4
Host: Rabbit
Antibody Isotype: IgG
Specificity: Human
Clone: C28G5
Application*: WB
Target: FLT4
Host: Mouse
Antibody Isotype: IgG2a, κ
Specificity: Human
Clone: 6B7
Application*: SE, E
Target: FLT4
Host: Mouse
Antibody Isotype: IgG1, κ
Specificity: Human
Clone: 5F11
Application*: WB, E
Target: FLT4
Host: Mouse
Antibody Isotype: IgG2a, κ
Specificity: Human
Clone: 5B5
Application*: WB, E
Target: FLT4
Host: Mouse
Antibody Isotype: IgG2b, κ
Specificity: Human
Clone: 2E3
Application*: WB, E
Target: FLT4
Host: Mouse
Antibody Isotype: IgG2a, κ
Specificity: Human
Clone: KLT9
Application*: P
Target: FLT4
Host: Mouse
Antibody Isotype: IgG1
Specificity: Mouse
Clone: 9G03
Application*: WB, IH
Target: FLT4
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: 9D9
Application*: WB, E, IH
Target: FLT4
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: 7G63
Application*: WB, P
Target: FLT4
Host: Rat
Antibody Isotype: IgG2
Specificity: Mouse
Clone: 5F63
Application*: WB, P
Target: FLT4
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: 8C8
Application*: E, WB, P
More Infomation
For Research Use Only. Not For Clinical Use.
(P): Predicted
* Abbreviations
IFImmunofluorescence
IHImmunohistochemistry
IPImmunoprecipitation
WBWestern Blot
EELISA
MMicroarray
CIChromatin Immunoprecipitation
FFlow Cytometry
FNFunction Assay
IDImmunodiffusion
RRadioimmunoassay
TCTissue Culture
GSGel Supershift
NNeutralization
BBlocking
AActivation
IInhibition
DDepletion
ESELISpot
DBDot Blot
MCMass Cytometry/CyTOF
CTCytotoxicity
SStimulation
AGAgonist
APApoptosis
IMImmunomicroscopy
BABioassay
CSCostimulation
EMElectron Microscopy
IEImmunoelectrophoresis
PAPeptide Array
ICImmunocytochemistry
PEPeptide ELISA
MDMeDIP
SHIn situ hybridization
IAEnzyme Immunoassay
SEsandwich ELISA
PLProximity Ligation Assay
ECELISA(Cap)
EDELISA(Det)
BIBioimaging
IOImmunoassay
LFLateral Flow Immunoassay
LALuminex Assay
CImmunohistochemistry-Frozen Sections
PImmunohistologyp-Paraffin Sections
ISIntracellular Staining for Flow Cytometry
MSElectrophoretic Mobility Shift Assay
RIRNA Binding Protein Immunoprecipitation (RIP)
Online Inquiry